Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS One. 2014 Apr 10;9(4):e94697. doi: 10.1371/journal.pone.0094697. eCollection 2014.

Use of targeted exome sequencing in genetic diagnosis of Chinese familial hypercholesterolemia.

Author information

  • 1Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China; Department of Atherosclerosis, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
  • 2Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China.
  • 3Department of Atherosclerosis, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.

Abstract

Familial hypercholesterolemia is an autosomal dominant inherited disease characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C). It is mainly caused by mutations of the low-density lipoprotein receptor (LDLR) gene. Currently, the methods of whole genome sequencing or whole exome sequencing for screening mutations in familial hypercholesterolemia are not applicable in China due to high cost. We performed targeted exome sequencing of 167 genes implicated in the homozygous phenotype of a proband pedigree to identify candidate mutations, validated them in the family of the proband, studied the functions of the mutant protein, and followed up serum lipid levels after treatment. We discovered that exon 9 c.1268 T>C and exon 8 c.1129 T>G compound heterozygous mutations in the LDLR gene in the proband derived from the mother and father, respectively, in which the mutation of c.1129 T>G has not been reported previously. The mutant LDL-R protein had 57% and 52% binding and internalization functions, respectively, compared with that of the wild type. After 6 months of therapy, the LDL-C level of the proband decreased by more than 50% and the LDL-C of the other family members with heterozygous mutation also reduced to normal. Targeted exome sequencing is an effective method for screening mutation genes in familial hypercholesterolemia. The exon 8 and 9 mutations of the LDLR gene were pedigree mutations. The functions of the mutant LDL-R protein were decreased significantly compared with that of the wild type. Simvastatin plus ezetimibe was proven safe and effective in this preschool-age child.

PMID:
24722143
[PubMed - in process]
PMCID:
PMC3983231
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk